Clearside Biomedical Inc (CLSD) — Cash Flow-to-Debt Ratio
Clearside Biomedical Inc (CLSD) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of $-5.48 Million could theoretically repay 0% of its total liabilities ($65.59 Million) in one year. Check Clearside Biomedical Inc (CLSD) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clearside Biomedical Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Clearside Biomedical Inc across 13 annual periods. Also explore Clearside Biomedical Inc (CLSD) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Clearside Biomedical Inc (2012–2024)
Year-by-year debt coverage analysis for Clearside Biomedical Inc. For market capitalisation and broader financial context, see CLSD market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.39x | $-24.70 Million | $63.98 Million | ▼ -6.3% |
| 2023 | -0.36x | $-18.14 Million | $49.93 Million | ▼ -10.6% |
| 2022 | -0.33x | $-13.37 Million | $40.70 Million | ▲ +84.9% |
| 2021 | -2.18x | $-10.73 Million | $4.93 Million | ▼ -75.3% |
| 2020 | -1.24x | $-13.12 Million | $10.56 Million | ▲ +28.3% |
| 2019 | -1.73x | $-27.07 Million | $15.62 Million | ▲ +55.1% |
| 2018 | -3.86x | $-79.20 Million | $20.50 Million | ▼ -44.3% |
| 2017 | -2.68x | $-51.08 Million | $19.08 Million | ▼ -55.1% |
| 2016 | -1.73x | $-22.71 Million | $13.15 Million | ▼ -616.7% |
| 2015 | -0.24x | $-13.90 Million | $57.71 Million | ▲ +22.1% |
| 2014 | -0.31x | $-9.12 Million | $29.51 Million | ▲ +41.8% |
| 2013 | -0.53x | $-6.84 Million | $12.88 Million | ▲ +88.1% |
| 2012 | -4.48x | $-3.18 Million | $709.00K | — |